Form 8-K - Current report:
SEC Accession No. 0001437749-25-009162
Filing Date
2025-03-25
Accepted
2025-03-25 16:35:08
Documents
14
Period of Report
2025-03-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tlry20250325_8k.htm   iXBRL 8-K 24767
  Complete submission text file 0001437749-25-009162.txt   162562

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tlry-20250325.xsd EX-101.SCH 3579
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlry-20250325_def.xml EX-101.DEF 11424
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20250325_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20250325_pre.xml EX-101.PRE 11584
16 EXTRACTED XBRL INSTANCE DOCUMENT tlry20250325_8k_htm.xml XML 2839
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray Brands, Inc. (Filer) CIK: 0001731348 (see all company filings)

EIN.: 824310622 | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 25768820
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)